Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
A ELN-Multicenter Study on Phenotypic Evolution and Clinical Outcomes
NCT07203768 · View on ClinicalTrials.gov ↗
Study Summary
International multicenter retrospective observational study consisting of two parts: a nested case-control study (part A) and a comparative retrospective cohort study (part B).
Conditions Studied
Study Locations (20)
Other
- University Hospital Halle — Halle
- Hannover Medical School — Hanover
- University Clinic for Hematology, Oncology, Hemostaseology and Palliative Care Johannes Wesling Medical Center — Minden
- A.S.O. SS. Antonio e Biagio e C.Arrigo, SC Ematologia — Alessandria
- ASST Papa Giovanni XXIII, SC Ematologia — Bergamo
- ASST-Spedali Civili — Brescia
- Ospedale Businco — Cagliari
- AOU Policlinico Vittorio Emanuele - PO Gaspare Rodolico — Catania
- AOU Careggi, Divisione di Ematologia — Florence
- ASST Grande Ospedale Metropolitano Niguarda, Divisione di Ematologia — Milan
- Fondazione IRCCS Cà Grande - Op. Maggiore Policlinico — Milan
- Ospedale San Raffaele — Milan
- ASST MONZA Ospedale San Gerardo Clinica Ematologica — Monza
- Azienda Ospedaliera Universitaria Federico II di Napoli Divisione di Ematologia e Trapianti del Midollo — Naples
- Azienda Ospedaliero Universitaria Maggiore della Carità di Novara SCDU Ematologia — Novara
- Presidio Ospedaliero di Pescara — Pescara
- Fondazione Policlinico Universitario Gemelli — Roma
Minnesota
- Mayo Clinic — Rochester
Lombardy
- Divisione Ematologia, Fondazione IRCCS Policlinico San Matteo — Pavia
Veneto
- Divisione Ematologia, Ospedale San Bortolo — Vicenza
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 678 participants |
| Start Date | 2025-12-01 |
| Est. Completion | 2026-07-31 |
Interested in This Trial?
Always speak with your doctor before enrolling in a clinical trial.
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07203768
The ClinicalTrials.gov registry entry for NCT07203768 describes a study currently listed as recruiting. It is categorized as an unspecified phase, which is the standard way researchers label where a study sits along the investigational pathway from early safety work through later efficacy and post-marketing evaluation. The registered enrollment target is 678 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS, which has 1 total studies on file at ClinicalTrials.gov, and sponsors are the parties responsible for study design, oversight, and regulatory filings.
The record links to 2 conditions, with Polycythemia Vera appearing as the primary indexed condition, and to 0 interventions. Interventions can include drugs, devices, procedures, behavioral programs, or observational arms, and each is tracked as a separate registry field so that downstream queries can filter accurately. When a trial lists multiple interventions, it usually reflects a multi-arm design or a comparison protocol rather than a single treatment being tested in isolation. The brief summary published in the registry is the clearest source of protocol intent and should be read before drawing conclusions from any sidebar tags.
Geographic footprint matters for practical reasons: NCT07203768 reports 20 study locations spanning 4 distinct geographic areas — top geographies include Other, Minnesota, Lombardy. A larger site network tends to correlate with broader recruitment capacity, but it does not imply anything about study quality, and site-level enrollment status can diverge from the overall registry status shown above. Every data point on this page comes from the public ClinicalTrials.gov dataset and is reproduced here for reference only; it is not a medical recommendation, an endorsement of the sponsor, or an invitation to enroll. Verify current status, eligibility criteria, and contact details directly at ClinicalTrials.gov, and discuss any participation decision with your own healthcare provider.
Frequently Asked Questions
What is clinical trial NCT07203768 about?
NCT07203768 is a clinical study titled "A ELN-Multicenter Study on Phenotypic Evolution and Clinical Outcomes". International multicenter retrospective observational study consisting of two parts: a nested case-control study (part A) and a comparative retrospective cohort study (part B).
What is the current status of trial NCT07203768?
This trial is currently recruiting. The enrollment target is 678 participants. The study started on 2025-12-01. Estimated completion is 2026-07-31.
What conditions does trial NCT07203768 study?
This clinical trial studies the following conditions: Polycythemia Vera, Thrombocythemia. These conditions were identified from the trial registry and reflect the primary focus areas of the research.
Who is sponsoring clinical trial NCT07203768?
This trial is sponsored by FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS, which has 1 total clinical trials registered on ClinicalTrials.gov. The sponsor is responsible for the study's design, funding, and regulatory compliance.
Where is trial NCT07203768 being conducted?
This trial has 20 study locations across Minnesota, Lombardy, Veneto. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How Clinical Trials Work
Understand phases 1-4, trial design, randomization, and the informed consent process.
Patient Rights in Clinical Trials
Your rights as a participant: consent, withdrawal, privacy, and who to contact.
Finding the Right Clinical Trial
A practical guide to searching trials, understanding eligibility, and evaluating options.
All Guides
Browse our complete library of clinical trial educational resources.
Read our methodology — how this data is sourced, computed, and verified.